RBC Raises Price Target on Neurocrine Biosciences to $145 From $137, Keeps Outperform Rating
Published on 06/05/2025 at 17:48

Published on 06/05/2025 at 17:48
Market Closed -
Other stock markets
|
||
132.02 USD | -1.56% |
Select your edition
All financial news and data tailored to specific country editions